These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 22000864

  • 1. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.
    Cheng MW, Wang BC, Weng ZQ, Zhu XW.
    Acta Histochem; 2012 Sep; 114(5):503-9. PubMed ID: 22000864
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
    Wang ZX, Xue D, Liu ZL, Lu BB, Bian HB, Pan X, Yin YM.
    Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
    [Abstract] [Full Text] [Related]

  • 3. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas.
    Jang YJ, Kim YS, Kim WH.
    Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274
    [Abstract] [Full Text] [Related]

  • 4. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].
    Chen XJ, Wu LM, Xu XB, Feng XW, Xie HY, Zhang M, Shen Y, Wang WL, Liang TB, Zheng SS.
    Zhonghua Wai Ke Za Zhi; 2007 Oct 01; 45(19):1354-8. PubMed ID: 18241575
    [Abstract] [Full Text] [Related]

  • 5. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
    Kanaji S, Saito H, Tsujitani S, Matsumoto S, Tatebe S, Kondo A, Ozaki M, Ito H, Ikeguchi M.
    Oncology; 2006 Oct 01; 70(2):126-33. PubMed ID: 16645325
    [Abstract] [Full Text] [Related]

  • 6. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ, Zhang S, Yang Y, Zhang N, Wang W, Liu SY, Tian HW, Dai L, Xie Q, Zhao X, Wei YQ, Deng HX.
    Cancer Biother Radiopharm; 2011 Aug 01; 26(4):427-36. PubMed ID: 21797676
    [Abstract] [Full Text] [Related]

  • 7. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
    Zhou Q, Bai M, Su Y.
    Ai Zheng; 2005 Feb 01; 24(2):149-54. PubMed ID: 15694023
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX.
    BMC Cancer; 2012 Nov 14; 12():519. PubMed ID: 23151088
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
    Yunoki T, Tabuchi Y, Hayashi A, Kondo T.
    Invest Ophthalmol Vis Sci; 2013 Dec 23; 54(13):8353-63. PubMed ID: 24366665
    [Abstract] [Full Text] [Related]

  • 13. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
    Ding Y, Huang D, Zhang Z, Smith J, Petillo D, Looyenga BD, Feenstra K, Mackeigan JP, Furge KA, Teh BT.
    Cancer Res; 2011 Aug 01; 71(15):5225-34. PubMed ID: 21642374
    [Abstract] [Full Text] [Related]

  • 14. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.
    Gastroenterology; 2012 Mar 01; 142(3):521-530.e3. PubMed ID: 22108192
    [Abstract] [Full Text] [Related]

  • 15. A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.
    Ikezoe T, Yang J, Nishioka C, Takezaki Y, Tasaka T, Togitani K, Koeffler HP, Yokoyama A.
    Leukemia; 2009 Sep 01; 23(9):1564-76. PubMed ID: 19421227
    [Abstract] [Full Text] [Related]

  • 16. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y, Yang Z, Li Q, Song F.
    Oncology; 2008 Sep 01; 74(3-4):198-206. PubMed ID: 18714168
    [Abstract] [Full Text] [Related]

  • 17. [Inhibition of polo like kinase gene expression induces apoptosis in gastric cancer cells].
    Lan B, Liu BY, Cheng XH, Qu Y, Zhang XQ, Cai Q, Zhu ZG.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan 01; 9(1):62-6. PubMed ID: 16437376
    [Abstract] [Full Text] [Related]

  • 18. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
    Lan B, Liu BY, Cheng XH, Qu Y, Zhang XQ, Cai Q, Dai QB, Zhu ZG.
    Zhonghua Wai Ke Za Zhi; 2006 Jan 01; 44(1):40-4. PubMed ID: 16620646
    [Abstract] [Full Text] [Related]

  • 19. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
    Lan B, Liu BY, Chen XH, Qu Y, Zhang XQ, Cai Q, Zhu ZG.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan 01; 10(1):70-2. PubMed ID: 17253180
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X, Choy E, Harmon D, Yang S, Yang C, Mankin H, Hornicek FJ, Duan Z.
    Anticancer Drugs; 2011 Jun 01; 22(5):444-53. PubMed ID: 21399492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.